Loading...
•
Oct 31, 2023
Cooper Q4 2023 Earnings Report
CooperCompanies reported strong Q4 2023 results, driven by revenue growth and improved profitability.
Key Takeaways
CooperCompanies announced Q4 2023 results with revenue of $927.1 million, up 9% organically. GAAP EPS was $1.70, up 29%, and non-GAAP EPS was $3.47, up 26%. The company's FY 2023 revenue reached $3.6 billion, up 10% organically.
Q4 2023 revenue increased by 9% to $927.1 million, with organic growth of 9%.
GAAP diluted EPS for Q4 2023 rose by 29% to $1.70.
Non-GAAP diluted EPS for Q4 2023 increased by 26% to $3.47.
Gross margin improved to 65% from 63% in the previous year.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Office & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
CooperCompanies initiated its fiscal year 2024 financial guidance, expecting total revenue of $3,809 - $3,877 million (organic growth of 6% to 8%) and non-GAAP diluted earnings per share of $13.60 - $14.00.
Positive Outlook
- Fiscal 2024 total revenue of $3,809 - $3,877 million (organic growth of 6% to 8%)
- CVI revenue of $2,548 - $2,594 million (organic growth of 7% to 9%)
- CSI revenue of $1,261 - $1,283 million (organic growth of 4% to 6%)
- Fiscal 2024 non-GAAP diluted earnings per share of $13.60 - $14.00
- Focus on gaining market share and driving profitability.
Challenges Ahead
- Guidance excludes amortization and impairment of intangible assets.
- Guidance excludes acquisition and integration costs.
- Uncertainty in forecasting acquisition-related, integration, and restructuring charges and expenses.
- Impact of continuing uncertainty and instability of certain countries.
- Potential adverse economic impact and related uncertainty caused by man-made or natural disasters and pandemic conditions.
Revenue & Expenses
Visualization of income flow from segment revenue to net income